Canopy Growth Corp (CGC) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CGC received an overall rating of 40, which means that it scores higher than 40 percent of all stocks. Canopy Growth Corp also achieved a score of 81 in the Drug Manufacturers - Specialty & Generic industry, putting it above 81 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 141 out of the 148 industries.
CGC has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on CGC!